UHC Medicare Advantage Prior Authorization Denial Appeal 2026: Step-by-Step Guide

Why UHC Medicare Advantage PA Denials Are Different from Commercial

UHC Medicare Advantage prior authorization denials operate under a completely different ruleset from commercial plan denials — and filing under the wrong process is one of the most common reasons appeals fail before they start.

The core differences that matter for billing teams:

• CMS-mandated timelines apply. Under CMS-0057-F (effective January 1, 2026), UHC must decide standard MA prior authorization requests within 7 calendar days and expedited requests within 72 hours. Commercial plans have no equivalent federal deadline.
• The appeal ladder has five formal levels set by CMS, not just an internal grievance process. After UHC's internal appeal, the next reviewer is an independent federal contractor — not another UHC department.
• Specialty pharmacy PA routes through OptumRx, not the main UHC Provider Portal. Filing a specialty drug PA appeal through the standard Authorization Manager sends it to the wrong queue and restarts the clock. For UHC commercial prior authorization submission and InterQual-based workflows, see the UHC prior authorization template guide.
• Imaging and musculoskeletal PA for select MA plans routes through eviCore, which has a separate peer-to-peer and reconsideration process from UHC's main UM team.
• Optum Health Networks now manages select MA administrative services (effective January 1, 2026). Your denial letter will identify whether UHC or Optum issued the denial — the appeal must go to the entity listed on the notice, not assumed to be standard UHC.

2026 CMS-0057-F Changes That Affect Your Appeal Timeline

The CMS Interoperability and Prior Authorization Final Rule (CMS-0057-F), in effect since January 1, 2026, changed how UHC Medicare Advantage handles prior authorization decisions and denials. These requirements apply to all UHC MA products — AARP MedicareComplete, Dual Complete, Group Medicare Advantage, and D-SNP plans.

What changed under CMS-0057-F:

• Standard PA decisions: UHC must respond within 7 calendar days of receiving a complete request. Previously, MA plans could take up to 14 days.
• Expedited PA decisions: UHC must decide urgent requests within 72 hours.
• Denial specificity: UHC must provide a specific clinical reason for each denial — rote denial codes like "does not meet criteria" without clinical justification no longer satisfy the rule. This means appeals now have a more actionable denial reason to address.
• Interoperability: UHC must share PA status data via API, making denial tracking more auditable than prior years.

The UHC Medicare Advantage PA Denial Appeal Ladder

UHC Medicare Advantage appeals follow a five-level federal structure. You must exhaust each level before proceeding to the next. Skipping a level forfeits your right to that stage of review.

Pre-Appeal: Request a Peer-to-Peer Review First

A peer-to-peer (P2P) review is not a formal appeal level, but it is your fastest path to reversal. Request it within one to two business days of the denial — call 877-842-3210 and ask to schedule a P2P with the UHC medical reviewer who issued the denial.

In a P2P, your physician speaks directly with UHC's reviewing physician to present the clinical rationale. For a broader guide covering UHC timely filing deadlines and appeal submission windows by plan type, see UHC appeal timely filing deadlines 2026. UHC does not require formal documentation for a P2P request — you need the patient's UHC member ID and the case reference number from the denial notice.

P2P reviews resolve a meaningful share of MA PA denials before formal appeal. If the P2P doesn't work, everything the UHC reviewer said becomes useful content for your Level 1 appeal letter.

Level 1: Internal UHC Medicare Advantage Appeal (File Within 65 Days)

The first formal step is UHC's internal reconsideration. File within 65 days of the denial notice date.

What to include:

• The denial notice (required — confirms the case reference number and plan type)
• A physician-signed appeal letter citing UHC's Clinical Decision Guidelines (CDGs) and the specific criteria your patient meets
• Updated clinical notes, lab results, and imaging reports addressing the stated denial reason
• Notes from the peer-to-peer review if one was held
• For imaging or MSK cases routed through eviCore: include the eviCore case reference number alongside the UHC denial notice

How to submit:

1. Log into UHC Provider Portal (uhcprovider.com) with your One Healthcare ID
2. Navigate to "Appeals and Grievances" → "Submit an Appeal"
3. Confirm the plan type is Medicare Advantage before selecting the appeal type
4. Upload clinical documentation and the signed appeal letter
5. Record the appeal confirmation number
6. UHC must respond within 30 days (standard) or 72 hours (expedited Level 1 appeal)

If Optum Health Networks issued the denial (listed on the denial notice header), submit the appeal to the address or portal specified on the Optum denial letter — not the standard UHC appeals path.

For a CDG-compliant medical necessity letter format built for UHC MA reviewers, see the UHC medical necessity letter template guide.

Level 2: IRE Reconsideration — Now C2C Innovative Solutions (File Within 60 Days of Level 1 Denial)

If UHC upholds the denial at Level 1, the next step is an independent federal review by the Qualified Independent Contractor (QIC) — also called the Independent Review Entity (IRE).

Critical 2026 change: The Part C IRE was MAXIMUS Federal Services through April 30, 2026. Effective May 1, 2026, C2C Innovative Solutions (C2C) replaced MAXIMUS as the IRE for Medicare Advantage appeals (CMS announcement, April 1, 2026). If your Level 1 denial was received before May 1, 2026, your IRE reconsideration may have been filed with MAXIMUS — check whether your case transferred or needs to be refiled with C2C.

Filing the Level 2 appeal:

• File within 60 days of receiving the Level 1 denial notice (5 days added to mail receipt by default)
• Submit to C2C at the address specified on your Level 1 denial notice, or via the CMS appeals portal
• Include all Level 1 documentation plus the Level 1 denial letter
• C2C must decide within 30 days (standard) or 72 hours (expedited)

The IRE reviews the case independently — it is not part of UHC. C2C applies the same Medicare coverage rules as UHC would, but decisions have a higher reversal rate for well-documented appeals because the reviewer has no financial stake in the denial outcome.

Level 3: Administrative Law Judge (ALJ) Hearing at OMHA (File Within 60 Days of IRE Decision)

If C2C upholds the denial, you may request an ALJ hearing through the Office of Medicare Hearings and Appeals (OMHA) within 60 days of receiving the Level 2 decision (plus 5 days for mail).

2026 eligibility threshold: The minimum amount in controversy for an ALJ hearing in calendar year 2026 is $200. This is the denied amount, not billed charges. Most PA denials for specialist services, imaging, or procedures exceed this threshold.

How to request an ALJ hearing:

1. File at hhs.gov/omha within 60 days of the IRE notice
2. Submit OMHA Form OMHA-100 (Request for ALJ Hearing or Review by a MAC)
3. Include all prior denial notices and Level 1–2 documentation
4. The ALJ will schedule a hearing (phone, video, or in-person) — typically 3-12 months out given OMHA caseloads

ALJ hearings are your strongest reversal opportunity for complex clinical cases where the CDG criteria are being applied incorrectly. The ALJ has the authority to override both UHC and the IRE.

Levels 4 and 5: Medicare Appeals Council and Federal District Court

Level 4 — Medicare Appeals Council (MAC): If the ALJ rules against you, request MAC review within 60 days. The MAC reviews the ALJ's legal interpretation, not the clinical facts anew.

Level 5 — Federal District Court: If the MAC upholds the denial, you may file in federal district court within 60 days. The CY2026 minimum amount in controversy for federal court is approximately $1,760. This level is rarely used for individual PA denials but applies to high-dollar cases or cases with precedent value.

UHC Medicare Advantage Plan-Type Portal Routing

UHC Medicare Advantage spans multiple product lines with different portal routing for PA submission and appeal. Filing to the wrong path — submitting an AARP MedicareComplete appeal to the commercial portal, or an OptumRx pharmacy appeal to the medical portal — resets processing time.

Expedited (72-Hour) UHC Medicare Advantage Appeal Process

Request expedited review when a delay in the service would seriously jeopardize the patient's life, health, or ability to regain maximum function. CMS-0057-F requires UHC to respond to expedited MA appeals within 72 hours.

How to request expedited review at Level 1:

1. Call 877-842-3210 and state explicitly: "I am requesting an expedited Medicare Advantage appeal for prior authorization denial"
2. Confirm the plan type is Medicare Advantage (not commercial) so the 72-hour CMS clock applies
3. Have the treating physician provide a verbal or written statement explaining why the standard 30-day review timeline would harm the patient
4. Fax or portal-upload supporting clinical documentation immediately — UHC cannot begin the 72-hour clock until the request is complete
5. Request a confirmation number and note the date and time of submission

If UHC denies your expedited request (i.e., they say the case doesn't qualify for expedited review), they must notify you within 24 hours and provide a reason. You can then escalate to the IRE (C2C) requesting expedited Level 2 review — C2C has a 72-hour timeline for expedited reconsiderations as well.

For Part D (specialty pharmacy) appeals under OptumRx: expedited drug appeals require a 24-hour response, not 72 hours, under CMS Part D regulations.

UHC Medicare Advantage PA Appeal Letter Template

For a general UHC appeal letter template covering commercial and MA plan denials, see the UHC appeal letter template 2026. The template below is specific to Medicare Advantage PA denials and references CDGs rather than InterQual.

Use this template for Level 1 internal UHC MA PA denial appeals. Submit via the UHC Provider Portal or to the address on the denial letter.

UnitedHealthcare Medicare Advantage Appeal — Prior Authorization Denial

DATE: [MM/DD/YYYY]
PATIENT NAME: [Last, First, MI]
DATE OF BIRTH: [MM/DD/YYYY]
UHC MEMBER ID: [Member ID from denial notice]
PLAN TYPE: Medicare Advantage — [AARP MedicareComplete / Dual Complete / Group MA]
DENIAL REFERENCE NUMBER: [From denial notice]
DATE OF DENIAL: [MM/DD/YYYY]

REQUESTING PROVIDER
Name: [Physician name and credentials]
NPI: [10-digit NPI]
Practice: [Practice name]
Phone: [Phone]
Fax: [Fax]

SERVICE DENIED
Service Description: [Specific service or procedure]
CPT/HCPCS Code(s): [Codes]
ICD-10 Diagnosis Code(s): [Primary and secondary diagnoses]
Requested Date(s) of Service: [Dates]

REASON FOR APPEAL
UnitedHealthcare denied this prior authorization on [denial date] citing: [exact denial language from notice].

We respectfully appeal this determination. The requested service is medically necessary for
this patient and consistent with UnitedHealthcare's Clinical Decision Guidelines (CDG) for
[condition/service category].

CLINICAL JUSTIFICATION

Patient Clinical History:
[Summary of diagnosis, onset, progression, and current functional status — 3-5 sentences]

Objective Clinical Findings:
- [Lab or test result with date and value]
- [Imaging finding with date]
- [Physical examination finding with measurement]

UHC CDG Compliance:
The requested [service] meets UHC's Clinical Decision Guidelines for [condition] because:
1. [Criterion 1 from CDG — how patient meets it]
2. [Criterion 2 from CDG — how patient meets it]
3. [Criterion 3 — if applicable]

Conservative Treatment History (if applicable):
1. [Treatment]: [Medication/intervention], [dates], [outcome/reason inadequate]
2. [Treatment]: [Details], [dates], [outcome]

Risk Without Requested Service:
Without [service], this patient faces: [specific clinical risk — disease progression,
functional deterioration, hospitalization, etc.]

Peer-to-Peer Notes (if held):
On [date], [physician name] spoke with UHC reviewer [name if available]. The reviewer
indicated [denial reason discussed]. We provide the following additional clinical evidence
in response: [brief response to P2P discussion].

SUPPORTING DOCUMENTATION ATTACHED
☐ This appeal letter (signed by treating physician)
☐ Denial notice [reference number]
☐ Clinical notes from [dates]
☐ [Diagnostic results] from [date]
☐ Peer-to-peer call record/notes (if applicable)
☐ Specialist consultation from [date]
☐ [UHC CDG excerpt or published guideline reference]

APPEAL TYPE
☐ Standard (30-day decision requested)
☐ Expedited — Clinical urgency documented below:
[If expedited]: Delay beyond 72 hours would harm this patient because: [specific reason]

PHYSICIAN CERTIFICATION
I certify the above information is accurate. The requested service is medically necessary
and consistent with evidence-based clinical standards.

Physician Signature: _______________________________
Physician Name (Printed): [Name, MD/DO/credentials]
Date: [MM/DD/YYYY]

SUBMISSION DETAILS
Submitted via: ☐ UHC Provider Portal ☐ Fax: [from denial letter] ☐ Mail: [from denial letter]
Confirmation Number: _______________

How Muni Appeals Handles UHC Medicare Advantage PA Denials

UHC Medicare Advantage PA appeals require a different workflow from commercial plan appeals — CDG citations instead of InterQual, a separate appeals portal for OptumRx and eviCore-managed services, and a strict five-level federal ladder that resets if you miss a deadline.

Independent practices handling UHC MA patients manually typically spend 45–60 minutes compiling each appeal: reviewing the denial reason, finding the applicable CDG criteria, gathering clinical documentation, and verifying which portal to use for that patient's specific plan type. A missed routing step or a wrong portal submission wastes that time without starting the clock.

Muni Appeals organizes the UHC Medicare Advantage appeal workflow from denial to submission.

• Routes each appeal to the correct portal by confirming plan type (AARP MedicareComplete, Dual Complete, Group MA, or Optum-managed) from the denial notice before drafting
• Generates appeal letters citing UHC's CDGs — not InterQual — using the specific denial reason from the notice
• Tracks the 65-day filing deadline from the denial date and alerts when action is needed
• Handles OptumRx Part D appeals separately from medical PA appeals, using the professionals.optumrx.com path
• Monitors the C2C IRE transition for Level 2 submissions filed after May 1, 2026

Start 3 Free Appeals →

Frequently Asked Questions

How long do I have to appeal a UHC Medicare Advantage prior authorization denial?

You have 65 days from the date on the denial notice to file a Level 1 internal appeal with UHC. For Level 2 IRE reconsideration (now C2C), you have 60 days from the Level 1 denial date. For Level 3 ALJ hearing, you have 60 days from the IRE decision. Missing any deadline closes that appeal level. If you received an Optum Health Networks denial (listed on the denial letter header), the same 65-day window applies but the submission address is different — use the address on the Optum denial notice.

What is the difference between a UHC commercial PA appeal and a Medicare Advantage PA appeal?

Commercial UHC PA appeals use InterQual criteria, have no federally mandated decision timeline, and go through UHC's internal grievance process only. Medicare Advantage PA appeals use Clinical Decision Guidelines (CDGs), have CMS-mandated timelines (7 calendar days standard / 72 hours expedited for initial PA decisions, 30 days / 72 hours for Level 1 appeals), and have a five-level federal appeal ladder ending at federal district court. The portals may look the same but are different systems — always confirm plan type before filing.

Who is the independent reviewer (IRE) for UHC Medicare Advantage appeals in 2026?

C2C Innovative Solutions replaced MAXIMUS Federal Services as the Part C IRE on May 1, 2026 (CMS announcement, April 1, 2026). Appeals filed with MAXIMUS through April 30, 2026 were processed under the previous contract. Level 2 appeals filed on or after May 1, 2026 go to C2C. Check your Level 1 denial letter for the current IRE submission address — it will reflect the change.

Does UHC Medicare Advantage use InterQual or CDGs for PA review?

UHC Medicare Advantage uses Clinical Decision Guidelines (CDGs) — not InterQual. UHC's commercial plans use InterQual. This is a critical distinction for appeal letters: citing InterQual in a UHC MA appeal signals to the reviewer that you may be confused about the plan type, and the clinical criteria cited won't align with what the reviewer is applying. Always cite CDGs for Medicare Advantage appeals. CDG summaries are available at uhcprovider.com → Policies → Clinical Guidelines.

How do I appeal a UHC Medicare Advantage pharmacy (Part D) prior authorization denial?

Part D specialty pharmacy PA denials for UHC Medicare Advantage patients are managed by OptumRx — not the standard UHC Provider Portal. File the appeal at professionals.optumrx.com or call 1-800-711-4555. The CMS Part D timeline differs: expedited drug appeals require a 24-hour response (not 72 hours). The five-level appeal ladder applies similarly, but the first two levels go through the plan's pharmacy benefit manager (OptumRx) rather than UHC's medical UM team.

What is an expedited UHC Medicare Advantage appeal and when should I request one?

Request expedited Level 1 appeal review when a delay beyond 30 days would seriously jeopardize the patient's life, health, or ability to regain maximum function. Call 877-842-3210 and state "expedited Medicare Advantage appeal." CMS-0057-F requires UHC to decide expedited MA appeals within 72 hours. The treating physician must certify the urgency — without this certification, UHC may downgrade to standard review and the 72-hour clock does not apply.

Why did UHC route my Medicare Advantage PA to Optum instead of the regular portal?

Effective January 1, 2026, Optum Health Networks assumed management of certain Medicare Advantage administrative services for select markets and service categories. For those members, prior authorization submission and appeal routing now go through Optum rather than standard UHC. The denial letter header will say "Optum Health Networks" if this applies. Run eligibility verification in the UHC Provider Portal before submitting — it will show whether the member routes through UHC or Optum for the relevant service category.

What is the success rate for UHC Medicare Advantage PA denial appeals?

According to CMS Medicare Advantage Organization Determinations, Appeals and Grievances Data (2023), approximately 80.7% of appealed UHC Medicare Advantage PA denials are partially or fully overturned. Despite this, fewer than 1 in 9 denied patients files an appeal — meaning the vast majority of reversible denials are abandoned at the initial denial stage. The reversal rate reinforces that complete documentation addressing the specific CDG criteria is the deciding factor in most outcomes.

Ready to Stop Losing UHC Medicare Advantage Revenue?

UHC Medicare Advantage prior authorization denials come with a defined federal appeal path — five levels, specific deadlines, and independent reviewers with no financial stake in the outcome beyond Level 1. The most common reasons appeals fail are process errors: wrong portal, wrong criteria framework (InterQual vs. CDG), missed deadlines, or incomplete clinical documentation.

With an 80.7% overturn rate for appealed MA denials, the revenue is recoverable. Most practices simply lack the workflow to pursue it consistently.

With Muni Appeals for UHC Medicare Advantage:

• Correct portal routing confirmed per patient before every submission
• Appeal letters citing CDGs — formatted for UHC's MA reviewer framework
• 65-day filing deadline tracked from denial date
• OptumRx Part D appeals routed separately with 24-hour escalation flag
• C2C IRE path updated for Level 2 submissions post-May 2026

Start 3 Free Appeals →

---

Updated June 2026. This guide reflects current UnitedHealthcare Medicare Advantage prior authorization denial appeal procedures, including CMS-0057-F requirements effective January 1, 2026, Optum Health Networks MA routing change effective January 1, 2026, and the C2C Innovative Solutions IRE transition effective May 1, 2026 (replacing MAXIMUS). CMS MA appeal timelines and routing may vary by plan contract and market. Verify current submission paths via uhcprovider.com or the entity named on your denial notice before filing. This guide does not constitute legal advice.